Immunogenicity of pneumococcal vaccine in persons with spinal cord injury.

[1]  E. Swiatlo,et al.  In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment. , 1997, Southern medical journal.

[2]  R. Breiman,et al.  Prevention of pneumococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1997 .

[3]  S. Quataert,et al.  Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S , 1995, Clinical and diagnostic laboratory immunology.

[4]  A. Jackson,et al.  Incidence of respiratory complications following spinal cord injury. , 1994, Archives of physical medicine and rehabilitation.

[5]  D. Musher,et al.  Pneumococcal vaccination for patients with spinal cord injury. , 1993, Archives of physical medicine and rehabilitation.

[6]  R. Breiman,et al.  Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. , 1993, JAMA.

[7]  S L Stover,et al.  Causes of death during the first 12 years after spinal cord injury. , 1993, Archives of physical medicine and rehabilitation.

[8]  J. Cruse,et al.  Decreased immune reactivity and neuroendocrine alterations related to chronic stress in spinal cord injury and stroke patients. , 1993, Pathobiology : journal of immunopathology, molecular and cellular biology.

[9]  Robert E. Lewis,et al.  Neuroendocrine-immune interactions associated with loss and restoration of immune system function in spinal cord injury and stroke patients , 1992, Immunologic research.

[10]  R. Adair,et al.  The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. , 1991, The New England journal of medicine.

[11]  R. Breiman,et al.  Pneumococcal vaccine--past, present, and future. , 1991, The New England journal of medicine.

[12]  L. Engelhart,et al.  Pneumococcal vaccine: efficacy and associated cost savings. , 1990 .

[13]  R. Marino,et al.  Atelectasis and pneumonia in acute spinal cord injury. , 1990, Archives of physical medicine and rehabilitation.

[14]  R. Facklam,et al.  Pneumococcal vaccination. Controversies and opportunities. , 1990, Infectious disease clinics of North America.

[15]  D. McRitchie,et al.  Impaired antibody production in blunt trauma. Possible role for T cell dysfunction. , 1990, Archives of surgery.

[16]  M. Niederman.  Strategies for the prevention of pneumonia. , 1987, Clinics in chest medicine.

[17]  H. Reines,et al.  Pulmonary complications of acute spinal cord injuries. , 1987, Neurosurgery.

[18]  P. Tabloski,et al.  Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment. , 1987, Journal of gerontology.

[19]  M. Lyons.  Immune Function in Spinal Cord‐Injured Males , 1987, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[20]  A. Cross,et al.  Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. , 1986, The New England journal of medicine.

[21]  D. Musher,et al.  Natural and vaccine-related immunity to Streptococcus pneumoniae. , 1986, The Journal of infectious diseases.

[22]  M. Devivo,et al.  Prevalence of spinal cord injury: a reestimation employing life table techniques. , 1980, Archives of neurology.

[23]  M. Hilleman,et al.  Protective efficacy of pneumococcal polysaccharide vaccines. , 1977, JAMA.

[24]  R. Bellamy,et al.  Respiratory complications in traumatic quadriplegia. Analysis of 20 years' experience. , 1973, Journal of neurosurgery.